prostate cancer

Showing NaN - NaN of 360

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Colorectal Cancer, Lung Cancer Trial in New York (Questionnaires, Interviews, 30-minute telephone or

Recruiting
  • Breast Cancer
  • +3 more
  • Questionnaires
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 8, 2023

Prostate Cancer Trial in United States (drug, device, procedure)

Recruiting
  • Prostate Cancer
  • Administration of IS-002
  • +2 more
  • San Francisco, California
  • +3 more
Jul 7, 2023

Prostate Cancer Trial in New York (Black Doctor Screening Video, White Doctor Screening Video, Black Patient Screening Video)

Completed
  • Prostate Cancer
  • Black Doctor Screening Video
  • +7 more
  • New York, New York
    NYU Langone Health
May 24, 2023

Prostate Cancer Trial in Mineola, New York (Two-Fraction Stereotactic Body Radiation Therapy (SBRT))

Not yet recruiting
  • Prostate Cancer
  • Two-Fraction Stereotactic Body Radiation Therapy (SBRT)
  • Mineola, New York
  • +1 more
May 9, 2023

Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)

Recruiting
  • Prostate Cancer
  • +2 more
  • Exercise Therapy
  • Los Angeles, California
  • +7 more
Feb 20, 2023

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)

Active, not recruiting
  • Prostate Cancer
  • 89Zr- DFO-MSTP2109A
  • 89Zr DFO-MSTP2109A
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer Trial in Lake Success, New York

Recruiting
  • Prostate Disease
  • +4 more
  • Prostate Biopsy
  • +2 more
  • Lake Success, New York
  • +2 more
Jan 27, 2023

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)

Active, not recruiting
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
Jan 12, 2023

Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)

Not yet recruiting
  • Prostate Cancer
  • 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
  • PET MRI Imaging
  • New York, New York
    Smilow Comprehensive Prostate Cancer Center
Jan 9, 2023

Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab
  • +3 more
  • Tucson, Arizona
  • +59 more
Dec 22, 2022

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Body Composition and White Adipose Tissue Inflammation

Active, not recruiting
  • Breast Cancer
  • +3 more
  • DEXA Scan
  • Godin Leisure Time Exercise Questionnaire (GLTEQ)
  • Milford, Massachusetts
  • +7 more
Dec 19, 2022

Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Miami, Florida
  • +4 more
Dec 14, 2022

Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)

Recruiting
  • Prostate Cancer
  • Port Saint Lucie, Florida
  • +8 more
Dec 13, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Campbell, California
  • +29 more
Dec 6, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in New Orleans, New York (225Ac-J591)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +1 more
Nov 15, 2022

Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Jonesboro, Arkansas
  • +204 more
Nov 30, 2022

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022